(Q43181428)

English

Infliximab for the treatment of refractory Adamantiades-Behçet disease with articular, intestinal, cerebral and ocular involvement

scientific article published on 29 January 2010

Statements

Infliximab for the treatment of refractory Adamantiades-Behçet disease with articular, intestinal, cerebral and ocular involvement (English)
29 January 2010
282-286

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit